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Abstract
Background: Specialized drug shops such as pharmacies and drug shops are increasingly becoming important
sources of treatment. However, knowledge on their regulatory performance is scarce. We set out to systematically
review literature on the characteristics, knowledge and practices of specialized drug shops in Sub-Saharan Africa.
Methods: We searched PubMed, EMBASE, WEB of Science, CAB Abstracts, PsycINFO and websites for organizations
that support medicine policies and usage. We also conducted open searches using Google Scholar, and searched
manually through references of retrieved articles. Our search included studies of all designs that described
characteristics, knowledge and practices of specialized drug shops. Information was abstracted on authors,
publication year, country and location, study design, sample size, outcomes investigated, and primary findings using
a uniform checklist. Finally, we conducted a structured narrative synthesis of the main findings.
Results: We obtained 61 studies, mostly from Eastern Africa, majority of which were conducted between 2006 and
2011. Outcome measures were heterogeneous and included knowledge, characteristics, and dispensing and
regulatory practices. Shop location and client demand were found to strongly influence dispensing practices.
Whereas shops located in urban and affluent areas were more likely to provide correct treatments, those in rural
areas provided credit facilities more readily. However, the latter also charged higher prices for medicines. A vast
majority of shops simply sold whatever medicines clients requested, with little history taking and counseling. Most
shops also stocked popular medicines at the expense of policy recommended treatments. Treatment policies were
poorly communicated overall, which partly explained why staff had poor knowledge on key aspects of treatment
such as medicine dosage and side effects. Overall, very little is known on the link between regulatory enforcement
and practices of specialized drug shops.
Conclusions: Evidence suggests that characteristics and practices of specialized drug shops differ across rural and
urban locations, and that these providers are highly responsive to client demand. However, there is a dearth in
knowledge on how regulatory enforcement influences their characteristics and practices, and what strategies can
be employed to strengthen the governance of the retail pharmaceutical sector.
Background
Private medicine retailers (PMRs) are fast becoming key
players in promoting access to medicines in low and
middle-income countries [1-4]. Previously viewed largely
as informal providers operating at the fringes of
legitimacy, PMRs have gained prominence in the recent
past, with recent global initiatives such as the Affordable
Medicines Facility for malaria (AMFm) exploring ways
of utilizing them as a vehicle for expanding coverage for
essential health services. The rising interest in retailers
has resulted in increased frequency of interventions tar-
geting their performance [5,6]. In Sub-Saharan Africa
(SSA), PMRs include shops that specialize in selling
medicines, and those licensed to sell a limited range of
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pre-packaged medicines alongside groceries and other
household items. The term specialized drug shops
(SDSs) denotes the former category; the latter is com-
monly referred to in the literature as general shops [2,6].
Specialized drug shops primarily include pharmacies; le-
gally recognized non-pharmacy drug shops (part II drug
shops); unregistered drug shops; and community-owned
drug shops [6]. The typology was discussed in a previous
review [6].
Like other providers, SDSs are subject to regulations
stipulating the minimum requirements for entry into the
business and quality of care. However, widespread regu-
latory infringement has been reported [2,7-11]. Reviews
have previously examined consumer behavior [1] and
interventions for improving services provided by retai-
lers [1,6,12]. However, no review has described regula-
tory practices of SDSs, despite the fact that this is the
group of PMRs most often seen as an integral part of
the formal health system, particularly where strategies
such as the AMFm are concerned. This is the main pur-
pose of the review.
Methods
Original studies of all designs that described knowledge,
characteristics, and practices of stand-alone SDSs in SSA
were included. These included independent primary
studies, evaluations conducted by non-governmental
organizations, and reports commissioned by develop-
ment partners. Reviews and opinion pieces were
excluded, as were studies on pharmacies operating
within health facilities, those looking at drug content,
and those that failed to specify whether study units were
SDSs or general shops. Finally, the review timeline was
restricted to 20 years (1989–2009, later expanded to in-
clude studies published in 2010 and January 2011). The
time cap was added to ensure the capture of studies
reporting relatively recent SDS experiences.
A search strategy that combines population and geo-
graphical location search terms was then developed and
applied to PubMed, EMBASE, CAB Abstracts and Psy-
cINFO (Table 1). We searched websites for the Inter-
national Network for the Rational Use of Drugs
(INRUD), e-Drug, WHO Essential Medicines and Man-
agement Sciences for Health, for project reports and
references to articles that may have some relevance.
Additionally, we conducted cited-reference searches in
the Web of Science database to identify studies citing
other relevant studies, and did open Google Scholar
searches using the terms outlined in Table 1. Finally,
references of retrieved articles were searched manually
for other relevant studies, and all references imported
into an EndNote X library. Duplicated articles were
removed from the library.
A total of 5,608 articles were identified (Figure 1) (Last
search: 11th February 2011), and screened separately by
2 reviewers (FW and EM) using the inclusion criteria
outlined above. Articles that did not meet the require-
ments were removed from the list. Where there was lack
of clarity, the 2 reviewers (FW and EM) discussed the
article’s content, and made a joint decision on whether
or not it should be included. At the end of the process,
62 articles were retrieved and included in the review. In-
formation was abstracted on author, year of publication,
country and location (rural or urban), study design and
sample size, outcomes investigated, and the key findings
(Table 2). For intervention studies, baseline values - rather
than post-intervention data - were abstracted, with the
underlying thought that pre-intervention values were a
better reflection of typical SDS practices within the re-
spective regions. Similarly, data was abstracted from the
control group in post-hoc evaluations. The studies were
heterogeneous in terms of outcomes reported, thus ren-
dering a meta-analysis of results inappropriate. Conse-
quently, a structured narrative synthesis was undertaken.
Results
A vast majority of the studies were descriptive cross-
sectional surveys. Studies from the Eastern African re-
gion contributed more than half of all studies reviewed
(Figure 2), with Tanzania alone having 17 studies.
Nigeria had the highest number in West Africa, with 13
studies. The Southern and Central African regions had
few studies overall. More studies were conducted in
rural/peri-urban areas compared to urban locations (42
Table 1 Search terms used in searching electronic databases
Group A: Target population [combined by ‘OR’] Group B: Geographical location [combined by ‘OR’]
drug retailer* OR medicine retailer* OR pharmacy OR pharmacies OR
drug shop* OR medicine shop* OR drug seller* OR medicine seller*
OR drug vendor* OR medicine vendor* OR drug store* OR medicine
store* OR pharmacies [MeSH] OR drug dispensing shop* OR medicine
dispensing shop* OR medicine outlet* OR drug outlet* OR medicine dealer*
AND Angola OR Benin OR Burkina Faso OR Burundi OR Cape Verde OR Central
African Republic OR Chad OR Comoros OR Democratic Republic of Congo
OR Djibouti OR Equatorial Guinea OR Eritrea OR Ethiopia OR Gambia OR
Guinea OR Guinea-Bissau OR Lesotho OR Liberia OR Madagascar OR
Malawi OR Mali OR Mauritania OR Mozambique OR Niger OR Rwanda OR
Sao Tome and Principe OR Senegal OR Sierra Leone OR Somalia OR
Sudan OR Tanzania OR Togo OR Uganda OR Zambia OR Cameroon OR
Congo OR Côte d'Ivoire OR Ivory Coast OR Ghana OR Kenya OR Nigeria
OR Zimbabwe OR Namibia OR Swaziland OR Botswana OR Gabon OR
Mauritius OR South Africa OR Seychelles OR Africa South of the Sahara
[MeSH] OR Sub-Saharan Africa
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compared to 34), with a few studies including both loca-
tions. A pattern showing an increase in the number of
studies over recent years emerged, with nearly two-
thirds of the studies reviewed being conducted over the
last 5 year band (2006–2011) (Figure 3). Studies reported
a wide range of outcomes including dispensing practices
(41 studies), availability of medicines [13], staff know-
ledge [14], staff and/or shop characteristics [15], and ad-
herence to policy guidelines or regulatory requirements
(16 studies) (Figure 4).
Characteristics of staff, commodities stocked, and shops
A wide variety of SDSs were encountered, including
pharmacies and non-pharmacy outlets. Non-pharmacy
SDSs included accredited drug dispensing outlets
(ADDOs) and the older part II drug stores (also referred
to as ‘duka la dawa baridi’ in Swahili) in Tanzania,
licensed chemical sellers (LCSs) in Ghana, patent medi-
cine vendors (PMVs) in Nigeria, rural drug vendors in
Eritrea, and drug shops in Uganda among others. Phar-
macies were found mainly in urban areas, with the non-
pharmacy SDSs operating more in rural areas [16-19].
Specialized drug shops were more likely to be found in
affluent and highly populated areas overall. In Tanzania
and Eritrea, for instance, a positive correlation was
reported between the number of medicine outlets and
village or town size [20,21]. As distribution of health fa-
cilities follows similar patterns, there is danger of low
density areas having neither a health facility nor an SDS;
indeed, half of ADDOs in Tanzania were located less
than one kilometer from a health facility [22].
Shop ownership varied across studies, but rural SDSs
were more likely to have owners or relatives working as
staff, whereas urban shops had a higher likelihood of
having employees. This phenomenon, seen in Kenya and
Nigeria [9,23,24], may explain Greer et al’s observation
of relatively low staff turnover among rural PMVs in Ni-
geria, where over half of staff had worked at the same
shop for over 4 years [25]. Although staff qualification
varied substantially, those working in pharmacies and
part II drug shops generally held higher qualifications
compared to those working in PMVs. In Kenyan phar-
macies for instance, nearly all staff were found to have
tertiary health-related training [24]; similarly, nearly all
staff working in Tanzanian part II drug stores and Ugan-
dan drug shops were reported to have some health-
related training [11,26,27]. The majority of staff were
nurse aides. In Nigeria on the other hand, PMVs were
found employing children under the legally mandated
age for dispensing (21 years), most being school going
children [9,28]. However, pharmacies in some areas were
also guilty of hiring staff with no qualifications after
obtaining registration; in Mali, for instance, majority of
individuals dispensing in pharmacies were found to have
no professional qualifications [15]. Although pharmacies
usually require pharmacy-trained staff, Somaliland was a
notable exception; there, medical doctors and nurses
were allowed to run pharmacies due to an acute short-
age of pharmaceutical staff [29].
Figure 1 Summary of the literature searching and reviewing processes.
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Table 2 Summary of study characteristics and findings
Ref No Author (year),
country of study
Number and type
of shops (staff)
Study design
(SCM)
Areas investigated Major findings
66 Abula et al (2006)
Ethiopia, urban
20 Pharmacies Cross-sectional
survey
Drug sources, sources of information,
handling of clients requesting for
partial doses, and patient referral
-Poor access to drug information; 80% get no up-to-
date information on medicines (and rely on inserts instead)
-All staff reported referring patients when required
-40% accept partial dispensing
70 ACTwatch (2009)
Benin, urban and rural
35 pharmacies
(30 registered and
5 rural outpost
pharmacies)
Cross-sectional
survey
Availability, price, and volume of
antimalarials sold
-77% stocked the first-line ACT, with 87% stocking
non-artemisinin antimalarials. Diagnostic tests
Knowledge of providers - Pharmacy charged higher prices compared to other
providers, but sold lower volumes overall
30 ACTwatch (2009) D.R
Congo, urban and
rural
31 pharmacies and
470 drug stores
Cross-sectional
survey
Availability, price, and volume of
antimalarials sold
-Both shops rarely stocked first-line (only 20-25%), but
most had artemisinin monotherapy in stock
-Both shop types did not generally do diagnostic tests
Knowledge and perceptions
of providers
-Pharmacies charged lowest prices for ACTs
-Drug stores sold the most, but had least knowledge
33 ACTwatch (2009)
Madagascar, urban
and rural
80 registered
pharmaciesand
162 rural pharmacies
Cross-sectional
survey
Availability, price, and volume
of antimalarials sold
-Only half stocked the first-line; majority had non-artemisinin
drugs, and did not do diagnostic tests
-Pharmacies charged highest prices for ACTs by far
Knowledge and perceptions
of providers
-They sold the highest volume of medicines, but only 59% knew
the recommended first-line treatment
29 ACTwatch (2009)
Nigeria, urban
and rural
38 pharmacies and
305 patent medicine
stores
Cross-sectional
survey
Availability, price, and volume
of antimalarials sold
-74% of pharmacies had first-line, compared to 8% for PMVs
-Both shop types did not generally do diagnostic tests
Knowledge and perceptions
of providers
-Pharmacies charged highest prices for recommended ACTs
-PMVs sold the most, but had least knowledge on treatment
32 ACTwatch (2009)
Uganda, urban
and rural
65 pharmacies and
188 drug stores
Cross-sectional
survey
Availability, price, and volume
of antimalarials sold
-57% of pharmacies had first-line; only 4% of drug shops
Knowledge and perceptions
of providers
-Both shop types rarely carried out diagnostic tests
-Pharmacies charged highest prices for recommended ACTs
-Drug stores sold the highest volume of medicines, but only 60%
knew the recommended first-line treatment
31 ACTwatch (2009)
Zambia, urban
and rural
49 pharmacies and
130 drug stores
Cross-sectional
survey
Availability, price, and volume
of antimalarials sold
-Most pharmacies sold ACTs, but only 6% of drug shops did
–Non-registered ACT also very common in pharmacies
-32% of pharmacies did diagnostic tests, but not drug stores
Knowledge and perceptions
of providers
-Pharmacy ACT prices were higher than drug stores
-Drug stores had much lower knowledge on first-line drug
25 Adikwu, M. U
(1996) Nigeria,
peri-urban
46 Patent medicine
stores
Cross-sectional
survey
Regulatory inspections,
characteristics and knowledge
of dispensers
-All staff aware of the law governing retailers in Nigeria
-Main suppliers were pharmaceutical representatives
-Sales boys and girls used in patent medicine stores
W
afula
et
al.BM
C
H
ealth
Services
Research
2012,12:223
Page
4
of
18
http://w
w
w
.biom
edcentral.com
/1472-6963/12/223
Table 2 Summary of study characteristics and findings (Continued)
68 Adisa et al
(2006) Nigeria,
urban
50 Pharmacies Cross-sectional
survey
Knowledge on characteristics,
ethics and perceived responsibility
with regard to phyto-pharmaceuticals
-3/4 scored below 53% on knowledge about the drugs
-1/3 had training on phyto-pharmaceuticals
-3/4 felt such drugs need Regulatory Authority governance
-3/4 felt pharmacists qualified to handle such medicines
56 Adu-Sarkodie
et al (2000)
Ghana, urban
48 pharmacies Baseline survey
before intervention
(SCM)
-Management practices
for STI clients
-About half of the shops took patient history before selling
-Only one-fifth counseled clients on partner notification
-Only one-fifth offered the recommended medicines
-Only 13% advised STI clients to use condoms
34 Amin et al, 2005,
Kenya, rural
20 Pharmacies Cross-sectional
survey
-Drug sales practices -Unregistered drugs found in some pharmacies
-Majority of drugs not within the registration period
-Regulation and registration
policy framework
-New first-line AL found in only 11% of pharmacies
-Sourced drugs mainly from wholesalers, never from vendors
-Adherence, stocking practices
60 Berih et al (1989)
Sudan, urban
63 pharmacies Cross-sectional
survey (SCM)
Drug dispensing practices -Only 5% recommended ORS despite wide availability, with
2/3 recommending antimicrobials which cost 4 times more
-63% took history before treatment; these were more likely
to refer child and less likely to recommend antimicrobials
-ORS use not related to availability or history taking
47 Blanchard et al (2005)
South Africa, urban
28 Pharmacies Cross-sectional
survey
Knowledge and attitudes of
pharmacists towards providing
emergency contraception
-Nearly all pharmacists sold at least one of the two ECPs
-Most were familiar with contraceptive indication and side
effects, but felt they should not be given to under 18s
-About 80% were willing to display promotional materials
62 Brieger et al (2004)
Nigeria, rural and
urban
149 patent medicine
shops; (820 observations)
Cross sectional
survey
Nature of interaction between
patent medicine vendors and
clerks and clients
-Quarter of clients shared problems with staff
-69% sold requested medicines, 30% gave treatment
suggestions, 21% gave instructions on medication use, and
19% asked questions about the illness
49 Brieger et al (2007)
Nigeria, rural
12 patent medicine
sellers
Qualitative
study
-Medicine sellers perceptions of
consumer color preferences for
medicines
-Sellers linked color to effects; yellow associated with malaria
because of symptoms of yellow urine and eyes
-Sellers had low opinion of white colored medicines
73 Buabeng et al (2008)
Ghana, urban and rural
35 pharmacies and 64
licensed chemical shops
Cross-sectional
survey
-Availability of antimalarials -SPs the most available antimalarial; ACTs less available, especially
in chemical shops and rural areas
-Policy adherence when
choosing drugs to dispense
-Poor adherence to policy guidelines when choosing drugs
-Unregistered and unrecommended drugs stocked
-Types of medicines stocked
51 Buabeng et al (2010a)
Ghana, urban and rural
35 pharmacies and 64
licensed chemical shops
Cross-sectional
survey
-Characteristics of staff -45% of pharmacies had professional staff (pharmaceutical or
nursing) compared to 5% for LCSs; 24% of pharmacy staff
could treat malaria with ACTs compared to 6% LCSs
-Knowledge of staff on malaria -76% of pharmacy staff knew symptoms of complicated malaria
compared to 43% in LCS-Practices on malaria prevention
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Table 2 Summary of study characteristics and findings (Continued)
65 Buabeng, K. O (2010b)
Ghana, urban and rural
35 pharmacies and 64
licensed chemical shops
Cross-sectional
survey
-Suitability of premises for
malaria services provision
-Most pharmacies clean and well lit compared to LCSs
-74% pharmacies had counseling area versus 19% of LCS
-88% pharmacies had fridge versus 22% of LCSs
-All pharmacies kept some records versus 47% of LCSs
-More pharmacies than LCSs had reference materials
40 Cohen et al (2010)
Tanzania, rural
226 part II drug shops Cross-sectional
survey
Range and patterns of availability
of antimalarials vis-à-vis geographical
and socio-economic determinants
-ACTs stocked more in shops located nearer towns
and/or nearer other shops and in more populous areas
(p<0.01)
-Shops near ACT-stocking facilities more likely to stock the
non-recommended SP medicines (p<0.01). Remote shops more
likely to sell antipyretics for fever than antimalarial
20 Fayemi et al (2010)
Nigeria, rural
97 Patent medicine
vendors
Cross-sectional
survey
-knowledge, dispensing practices,
and referral for emergency
contraceptives
-One-third not aware of ECPs; only half knew that ECPs
could prevent pregnancy
-Only half had referral systems for ECP clients
58 Goel et al (1996)
Kenya, rural and
urban
91 Pharmacies Cross-sectional
survey (SCM used)
Influence of geographical location
and knowledge on prescribing
practices for diarrhea
-No clear relationship between knowledge and prescribing
-Correct treatment odds higher in high SES urban areas -
-Women more likely to receive appropriate treatment for
diarrhea in their children
28 Goodman (2004)
Tanzania, rural
43 Part II drug shops Cross-sectional
survey
Range and sources of antipyretics,
antibiotics and antimalarials
-Nearly all drug shops had fever and malaria medicines, and
nearly two-thirds had antibiotics
-87% got drugs from drug wholesaler or part I pharmacy
54 Goodman et al (2007)
Tanzania, rural
30 part II drug stores Cross-sectional
survey
Compliance with regulations -Majority displayed permits, but some permits belonged to staff
not attached to the shop. Majority also stocked and sold
prescription medicines against regulatory requirements
Likely causes of regulatory infringement -Poor compliance cause by low knowledge, inadequate inspections,
and tacit permission from regulatory enforcers
22 Greer et al (2004)
Nigeria, rural
245 patent medicine
vendors
Baseline survey
before intervention
(SCM)
-Characteristics and knowledge of PMV
on malaria and other diseases
-57, 28% had secondary or tertiary education respectively
-Stability in employment; 80% had worked there for over 1 year,
54% more than 4 years, 24% for more than 10 years
-21% knew ITNs, but only 5% recommended to clients
22 Greer et al (2004)
Uganda, rural
Baseline survey
before intervention
(SCM)
-Management of malaria, ARI
and diarrhea
-Majority took basic patient history appropriately
-Nearly all recommended wrong medicine and dose
-Only 8% explained how drug should be taken
42 Hera (2006) Tanzania,
rural and peri-urban
25 ADDOs Post-hoc ADDOs
programme
evaluation
Availability, affordability and quality
of drugs, and the quality of
dispensing services
Better availability but higher prices of drugs compared to
public facilities. Rural shops sold at higher prices, but disparities
among ADDOs in prices. Amoxicillin, quinine and ORS dispensed
inappropriately
17 Hetzel et al (2006)
Tanzania, rural
10 drug stores
before, 19 after
Cross-sectional
surveys
-Availability and access to drugs
before and after policy change
from chloroquine as first line to SP
-Number of shops stocking drugs almost doubled.
-First-line drug (SP) had better availability in 2004 than did CQ
(previous first-line) in 2001 (in drug shops)
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Table 2 Summary of study characteristics and findings (Continued)
23 Hetzel et al (2008)
Tanzania, rural
29 part II drug stores Cross sectional
survey
(SCM used)
-Knowledge on malaria treatment -Drug shops had better knowledge than general shops
-drug prescribing practices -Mystery shoppers likely to get appropriate treatment in drug
shops but at higher price.
-Adults more likely to have an anti-malarial sold to them
52 Igun (1994) Nigeria,
rural
58 pharmacies and
77 patent medicine
stores
-Cross-sectional
survey
(SCM used)
-Knowledge and prescribing
practices for watery and bloody
diarrhea
-70% of staff said they would give ORT for diarrhea, but only
7% actually gave, the rest giving drugs
-57% stated they give ORT only, but 90% of these providers
gave drugs only for the diarrhea
13 Jacobs et al (2004)
Uganda, rural and
peri-urban
141 drug shops Cross-sectional
survey
-Management of urethral discharge
in men, treatment outcomes, and
patients’ perception of quality of care
-14% of patients treated according to national guidelines, but
11% managed properly
-55% told to use condom or refer partner
- 38% cure rate
41 Karim et al (1996)
South Africa, urban
10 pharmacies Records review -Generic substitution -45.7% of all prescription had generic equivalents
-Cost analysis of prescriptions
for branded and generic drugs
- The branded price was 10% higher than the generic price
-Pharmacists only substituted 14% of drugs for generics
-7% of costs can be saved through generic substitution
74 Kachur et al (2006a)
Tanzania, urban
29 part I pharmacies Cross-sectional
survey
-Availability, packaging and labeling
of artemisinin-containing products
- 89% of artemisinin drugs identified were monotherapies
-All products sold as prepackaged unit doses
-All drugs obtained in manufacturers' original packaging
69 Kachur et al, (2006b)
Tanzania, rural
10 specialist drug stores Cross-sectional
survey
-Prevalence of malaria parasitemia
among clients
-17% of febrile visits resulted in buying of an antimalarial
-Characteristics of malari -An antipyretic as obtained in 77% visits, with most clients
not getting malaria-specific treatment when warranted
a and fever medicines buyers -Education linked to better buying of antimalarials
43 Kagashe et al (2011)
Tanzania, urban
70 pharmacies Cross-sectional
survey
-Dispensing practices for antibiotics,
and other drugs
-45% dispensed on client request, 32% on dispenser
recommendation, and only 23% on prescription
-Antibiotics given inappropriately and in partial doses
21 Kwena et al (2008)
Kenya, urban
50 pharmacies Cross-sectional
survey (SCM)
-Characteristics of providers
managing STI patients
-Only 10% of clients were offered appropriate treatment
according to the government’s STI management guidelines
-Knowledge on management of
STIs, compliance to guidelines
-74% of pharmacy staff reported that some customers
cannot raise all money for medicines prescribed
63 Liambila et al (2010)
Kenya, urban
20 pharmacies Survey before
intervention (SCM)
-Counseling and dispensing practices
for clients seeking emergency contraception
-About half of staff gave additional information on EC
-Only 12.5 gave regular family planning advice
-Only 5% talked about STIs/HIV
26 Maiga et al (2003)
Mali, urban
11 Pharmacies Records review Drug prescription and selling practices -Most purchases made without prescription were generics
-Transactions were more costly in pharmacies than public
health facilities (prices higher by 68%)
72 Maiga et al (2010)
Mali, urban
30 Private drug stores Survey before
intervention
Availability and prices for essential
medicines
- Availability of 49 essential drugs was 66.1% among the retail pharmacies
-Retail prices were 25% higher than recommended
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Table 2 Summary of study characteristics and findings (Continued)
35 Manirakiza et al (2010)
Central African Republic,
urban
15 Private drug stores
and 60 non-official
drug shops
Cross-sectional
survey
-Availability of antimalarials -87% of drug stores sold artemisinin monotherapy
-Performance of staff in management
of malaria
-70 and 93% of drug stores and unofficial drug shops sold
the unrecommended chloroquine
-Chloroquine was not supplied by the official wholesalers
-SP, the official treatment, was available in all drug stores,
but unavailable in 84% of unofficial drug shops
44 Massele et al (1993)
Tanzania, urban
20 drug shops Cross-sectional
survey
-Knowledge and treatment practices
for malaria
-Knowledge of drug sellers on sign and symptoms was
adequate, but 45% did not know the correct drug dose
-Only 30% of patients knew the correct dose
61 Mayhew et al (2001)
Ghana, urban
248 pharmacies Survey before i
ntervention (SCM)
-Characteristics of shops, staff and clients -Only 34% of staff had university qualification
-STI management of clients -60% of STI clients visit without a prescription
-Only 17% used national guidelines to treat STIs
27 Mazzilli et al, 2009
Somaliland, urban
and rural
83 pharmacies Cross-sectional
survey
-Characteristics of shops, staff -No pharmacists found. Nurses own most pharmacies
-Pharmacies offered injections and diagnostic tests
-Knowledge about drugs -Majority knew drugs through self study and experience
-Services and drugs offered -Majority sold medicines without prescription
7 Minzi et al (2008)
Tanzania, urban
551 pharmacies Cross-sectional
survey
-Types of antimalarials stocked
at the pharmacies
-None of had been involved in preparation of guidelines
-Poor knowledge on pediatric dosages
-Awareness on new malaria
treatment guidelines
-49% of pharmacies still stocked chloroquine
-Only 30/7% knew dose regimen of SP/AL respectively
18 Murray et al (1998)
Eritrea (rural)
59 rural drug vendors Cross-sectional
survey (SCM)
-Knowledge and treatment practices
for diarrhea and respiratory infection
-41% gave correct treatment for respiratory infection
-Only 38% of clients knew correct dosing for antibiotics
-63% knew how to treat diarrhea, but only 10% did so
14 Nakyanzi et al (2010)
Uganda, urban
32 pharmacies Cross-sectional
survey
-Range and characteristics of medicines
that expire within pharmacies
-75% had gotten low-price/donations of near-expiry drugs;
56% had disposed of expired drugs; 44% had returned
drugs to suppliers, and 28% had customers return drugs
-Policy change in treatment linked to expiry of medicines
36 Noor et al (2009)
Somalia, rural
194 pharmacies Cross-sectional
survey
-Availability of malaria drugs and
diagnostic services
-Over 30% do diagnosis; CQ found in 53% of shops, with
9% providing SP. Artemisinin monotherapy was found in
14% of shops, with one area having 42% availability
-Prescribing for malaria -ACT only found in 9% of shops (2 years after new policy)
45 Nshakira et al (2002)
Uganda, rural
2 drug shops Cross –sectional
survey
-Drugs and instructions given to children under five - 75% of medication was bought in shops in community
-Instructions given to caretakers
about dosage
-All study sites had a range of ant malarial drugs in stock
-An average of 3.2 drugs was dispensed per child
59 Nsimba (2007)
Tanzania, rural
4 pharmacies and
39 drug stores
Cross-sectional
survey (SCM used)
-Dispensing practices for ORS,
antimalarials and antibiotics
-Antibiotics overused in both urban and rural settings
-Use of branded drugs more common than generics
-Training on selectively prescribing -ORS rarely prescribed. Antibiotics inappropriately dispensed
for watery diarrhea in almost half of the cases
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Table 2 Summary of study characteristics and findings (Continued)
8 Ntambwe et al (1994)
Zaire (now D.R. Congo),
rural
44 pharmacies Cross-sectional
survey
-Characteristics of premises, staff,
and availability of permit
-None run by pharmacist or assistant. 30% run by nurses;
71% run by untrained persons; all shops owned by traders
-Compliance with dispensing and
recording regulations
-None had a permit, and none kept prescription registers
-87% sold drugs without prescription
64 Nyazema et al (2007)
Zimbabwe, urban
63 pharmacies Cross –sectional
survey (SCM used)
Sale of antibiotics without prescription,
and provision of treatment advice
according to acceptable standards
-69% said they can’t sell antibiotics without prescription
-Actual sale of antibiotics without prescription was low
-Few respondents performed well regarding provision of
information and advice in relation to treatment guidelines
9 Ojuawo et al (1993)
Nigeria, urban
75 Patent medicine
sellers
Cross –sectional
survey (SCM used)
-Knowledge, treatment and referral
practices for diarrhoea
-33% were owners. 30% of employees were primary school
children. Majority of staff did not ask questions about
diarrhea, and lacked knowledge on ORT
-Diarrhea drugs were recommended by all respondents
48 Okeke et al (2006)
Nigeria, rural
13 patent medicine
sellers
Survey before
intervention
Knowledge, beliefs, treatment practices,
and referral for mild and severe malaria
-Majority of sellers not health professionals
-Poor knowledge, dispensing, and referral for malaria
-Advice and information rarely given to care-givers
-62% dispensed what clients demand; only 15% took history
37 Onwujekwe et al (2010)
Nigeria, rural
11 pharmacies and
137 patent medicine
sellers
Cross-sectional
survey
-Characteristics of providers -14% of PMVs sold medicines without any diagnostic steps
compared to 5% for pharmacies. A high proportion of both
shops used history to confirm diagnosis for malaria
-Knowledge and management
of malaria
-More pharmacies sold artemisinin monotherapies
53 Oreagba et al (2010)
Nigeria, urban
400 pharmacies Cross-sectional
survey
-Knowledge, perceptions and
practice around pharmacovigilance
-55% had heard of pharmacovigilance; 18% could define it
-Only 3% reported adverse drug reactions to the authority
-45% did not report because they did not know how
46 Oshiname et al (1992)
Nigeria, rural
37 patent medicine
vendors
Baseline before
intervention
-Knowledge on symptoms, counseling
and management of malaria and
other diseases
- 70% knew the correct malaria drug, but only one knew
the correct dosage for a 3 year old child
-39% would sell medicine to a child
19 RPM Plus (2006),
Tanzania urban
and rural
58 ADDOs Cross –sectional
survey (SCM)
Knowledge and management of major
childhood illnesses, and availability of
key drugs
-Poor knowledge on treatment choices for diarrhea and ARI
-Low adherence to national guidelines for treating ARI,
malaria and diarrhea
16 Russo et al (2010)
Mozambique urban
34 private pharmacies Cross-sectional
survey
-Prices for generic and branded medicines -Huge price variations across pharmacies despite price regulation
-Pharmacies adjust prices depending on the market demand
38 Sabot et al (2009)
Tanzania, rural
Baseline survey
before
intervention
-Availability and dispensing practices
for ACTs
-Nearly none of the shops stocked the recommended ACTs
before the intervention (subsidy) was introduced
-As a result, most shops did not suggest/offer ACTs to clients,
choosing to instead offer SPs
11 Tumwikirize et al
(2004) Uganda,
urban
28 pharmacies and
169 drug stores
Cross-sectional
survey
-Characteristics, knowledge and
dispensing practices for ARIs
-Most staff had training background in nursing
-Low knowledge on ARI symptoms and management
-Inappropriate dispensing of antibiotics very common
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Table 2 Summary of study characteristics and findings (Continued)
39 van den Boogaard
et al (2010) Tanzania,
rural
14 pharmacies and
15 drug shops
Cross-sectional
survey
-Availability and sale of floroquinolones
and other antibiotics
-All drug shops illegally stocked and sold antibiotics
-Floroquinolones widely available in shops, raising concerns
over resistance
24 Viberg et al (2009)
Tanzania, rural
94 pharmacies, drug
stores, and ADDOs
Cross –sectional
survey
(SCM used)
-STI management practices -74% of drug sellers stated they had no STI-related drugs in
the stock, but 78% and 63% gave male and female simulated
clients the medicines, mostly antibiotics
-Knowledge on dose, side effects
-Drug dispensing practices -Most drugs dispensed were the recommended, though incomplete
management, incorrect dosages, lack of advice, and poor
history-taking were common
-Knowledge on regulation
50 Viberg et al (2010)
Tanzania, rural
75 drug sellers Cross-sectional
survey
-Knowledge and perceptions on
antibiotic use and resistance
-79% of drug sellers knew antibiotics treat
bacterial infections; 24% of these sellers also
thought antibiotics could treat viral infections
-72% had heard about antibiotic resistance
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SDSs were well stocked overall, although urban phar-
macies were generally better stocked compared to their
rural counterparts. In Somaliland for instance, urban
and rural pharmacies had 70% and 40% of specified es-
sential medicines respectively [29]. Drug shops were
found to have good availability of a narrower range of
medicines, usually fever and malaria drugs [20,30]. How-
ever, good availability did not always mean good geo-
graphical access to recommended treatments. This was
particularly seen in the case of antimalarials, where
the more widely available drugs were not the recom-
mended first-line treatments. This trend was seen in
Kenya, Uganda, Tanzania, Madagascar, Nigeria, Zambia,
Somalia and the Central African Republic [13,14,31-39].
In Tanzania, pharmacies were more likely to stock non-
recommended antimalarials if they were located near
health facilities that stocked the recommended drugs
[40]. Drug expiry was a problem in some areas but not
others. In Uganda, nearly half of the shops reported
cases of drugs expiring, whereas only one case was
observed in Somaliland [17,29]. Generic substitution was
rarely done; in South Africa for instance, only 14% of
pharmacists substituted branded drugs, despite the fact
that nearly half of prescribed medicines had generic
equivalents [41].
Knowledge and perceptions
Staff knowledge was assessed at two broad levels; know-
ledge specific to treatment, and knowledge on wider
aspects of practice such as treatment policies. Know-
ledge on drug specific aspects was found to vary sub-
stantially, although certain patterns were consistent
across studies. Majority of staff knew what drugs to give
for tracer conditions, but had less knowledge on appro-
priate dosing. This was seen in Tanzania [7,26,27,42-44],
Uganda [25,45], Eritrea [21], and Nigeria [31,46]. Mis-
conceptions were also reported: for instance, most South
African pharmacists erroneously believed that emer-
gency contraceptive pills (ECPs) posed health risks if
used repeatedly [47], majority of Nigerian PMVs believed
fever medicines could cure malaria on their own [48],
and that white colored medicines were less efficacious
overall [49], and nearly one-fifth of Tanzanian drug sell-
ers thought that antibiotics could cure viral infections
[50]. Where pharmacies and non-pharmacy SDSs were
compared, the former performed better overall. In
Figure 2 Distribution of studies by geographical location.
Figure 3 Distribution of studies across different time periods.
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Ghana for instance, three quarters of pharmacy staff
knew symptoms of complicated malaria compared to
43% for LCSs [51]. A few studies went further and com-
pared knowledge to practice. In Nigeria, 70% of pharma-
cies and PMVs knew oral rehydration therapy (ORT) to
be the treatment of choice for diarrhea and yet a vast
majority sold antidiarrhoeals and antibiotics instead [52],
whereas only 10% of Eritrean rural drug vendors gave
correct diarrhea treatment, despite the fact that 63%
knew the correct treatment [21]. Similarly, amodiaquine
and quinine were sold as much as sulphur medicines in
Tanzanian drug stores, despite staff knowing that only
the latter was recommended for uncomplicated malaria
at the time [26]. Discordances between knowledge and
practice extended beyond treatment; in another Tanza-
nian study for instance, only a few ADDOs advised mal-
aria clients to sleep under an ITN, despite the majority
knowing about the effectiveness of bednets as a prevent-
ive strategy [22]. Similarly, although 55% of Nigerian
pharmacies knew about pharmacovigilance, only one
fifth of pharmacies had actually made an attempt to re-
port an ADR to relevant authorities [53]. Knowledge on
broader policy issues was good overall, with all PMVs in
a Nigerian survey knowing about prescription-only
medicine status [28], and majority of Tanzanian drug
stores being aware that they were only allowed to sell
certain medicine categories, although there was consid-
erable confusion on which malaria medicines fell in this
category [54]. There were rural-urban differences in
knowledge on policy issues in Somaliland, with rural
pharmacies being less aware of the difference between
prescription and non-prescription drugs, and rationale
behind restricting the former [29].
Dispensing practices
Dispensing practices were grouped into three cat-
egories; treatment practices, communication, and cli-
ent referral. Most studies touched on more than
one category, with some exploring associations be-
tween dispensing practices and factors such as shop
location, staff qualification, and client characteristics
(age, sex, level of education and familiarity to the
attendant).
Studies assessing treatment practices looked at a wide
range of factors, including drug selection, adherence to
treatment protocols and dispensing without prescription.
The degree to which SDSs adhered to treatment guide-
lines was varied but low overall. Adherence to national
guidelines when managing STI clients was low in Kenya
(27% adherence) [55], Ghana (20-23%) [56,57], and
Uganda (8-14%) [16,25]. Inappropriate dispensing was
also observed for diarrhoea in Kenya [58], Tanzania
[43,59], Nigeria [9,52] and Sudan [60]. However, good
performers were also noted; in Tanzania for instance, 80
- 90% of drug stores dispense drugs recommended in
national guidelines for STIs, although the authors noted
the irony in the fact that the shops were not allowed to
stock the medicines in the first place [27]. It appeared
that some respondents were not completely honest in
their responses, possibly because they knew that they
were engaged in unlawful behavior. In another Tanza-
nian study for instance, three-quarters of drug stores
reported not having medicines for sexually transmitted
infections (STIs) in stock, and yet these drugs were dis-
pensed to 63% and 78% of female and male mystery
shoppers respectively [27].
Like treatment practices, communication with clients
gave mixed results. Shops were more likely to communi-
cate basic medication instructions after selling medicines
than take patient history before treatment, or offer advice
on alternative management strategies. Basic advice and
treatment instructions (how and when to take medicines)
were given in Ghanaian pharmacies (89% of clients), and
Tanzanian drug stores and ADDOs (89 and 93% respect-
ively) [22,27,61], but rarely done in Kenyan pharmacies
(17%) and Nigerian PMVs (10-13%) [9,55]. More technical
aspects such as side effects and contra-indications were
Figure 4 Distribution of the main outcomes reported.
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rarely discussed among drug stores in Tanzania and PMVs
in Nigeria [22,27,48]. Clients who requested specific drugs,
or those who failed to disclose the purpose of purchasing
medicines were less likely to receive advice in Nigeria and
Uganda [16,62]. Pharmacies on the other hand performed
relatively well in counseling, with nearly two-thirds of
South African pharmacies discussing prevention of preg-
nancy with contraception clients [47], and majority of
Ghanaian and Kenyan pharmacies counseling STI clients
on the importance of partner treatment (81 and 84% re-
spectively) [55,61]. Pharmacies also offered more privacy
during counseling, as seen in Zimbabwe, Kenya and So-
maliland [29,63,64]. In Ghana, three quarters of pharma-
cies had designated counseling areas compared to 19% of
LCSs [65]. Patient history taking was observed to be
poorly done in a number of studies. This was seen in
Ghana, Nigeria and Sudan [9,56,60]. Nigerian PMVs were
more likely to ask questions about illness if the shop was
located in a rural setting, if the attending staff was the
owner, or if the client was buying the drug for another
person [62].
Majority of staff interviewed in Ethiopia, Tanzania,
Somaliland, Nigeria and Ghana expressed willingness to
refer clients when necessary [26,29,48,61,66]. However,
actual referral practices were rarely investigated, and
where this was done, the practice was scarcely reported.
In Nigeria and Uganda for instance, nearly all staff failed
to refer clients when required [11,62]. What made refer-
ral particularly hard to assess was poor record keeping,
an observation made in Ugandan and Tanzanian drug
stores, as well as Ghanaian LCSs [22,65,67]. Pharmacies
kept better records , although it was not clear whether
this included referral records [65].
So, what factors influence dispensing behavior among
SDSs? A number of studies explored determinants of
SDS practices across different countries. In Nigeria, 3
separate studies found demand to be an important influ-
ence, with 40% of pharmacists and 62-69% of PMVs sell-
ing medicines at the request of clients [48,62,68].
Similarly, Ugandan and Tanzanian drug shops sold
whichever medicines clients requested [11,43,69],
whereas in Kenya and Somaliland, demand was reported
to influence pharmacies’ choice of medicines to stock
[24,29]. Another important determinant of dispensing
practices was shop location, with shops situated in urban
and affluent areas providing better services overall. This
was seen in Zimbabwe and Kenya for instance. In Zim-
babwe, pharmacies located in the capital had a higher
likelihood of dispensing correct STI treatments, whereas
clients visiting pharmacies located in urban or affluent
areas were more likely to receive appropriate treatment
in Kenya [58,64]. Additionally, shops located near towns,
those operating close to other shops, and shops situated
in more populous areas were found to have a higher
likelihood of stocking the first line antimalarial treat-
ments in Tanzania, meaning individuals staying within
such localities had better geographical access to policy
recommended treatments [40]. The same study also
found shops operating in remote areas to have a higher
likelihood of selling antipyretics in place of antimalarials
for fever (the policy at the time was to treat all fevers as
malaria cases in high transmission areas). Shop location
was associated with medicine prices and credit facilities.
In Tanzania, ADDOs operating in more rural areas were
found to have higher mark-ups compared to those in
urban locations [42], whereas medicines prices were
higher in pharmacies operating in more affluent parts of
Mozambique’s capital [19]. In Somaliland, four-fifths of
rural pharmacies offered credit facilities compared to
only half in urban locations [29]. Prices also varied with
shop type, with non-pharmacy drug shops having lower
prices compared to pharmacies in Nigeria, Uganda,
Benin and Zambia [14,31,33,70]. Regulation of retail
mark-ups was only encountered in Mali and Mozam-
bique [19,71,72]. Age and sex of client also had some as-
sociation with dispensing, with women receiving correct
diarrhoea treatment more often than men in Kenya, and
drug shops expressing higher willingness to sell medi-
cines for sick adults than infants in Tanzania [26,58]. Fi-
nally, familiarity with the clients influenced dispensing
in Zimbabwe, where one-fifth of pharmacy staff admit-
ted they could sell an antibiotic to an acquaintance with-
out asking for a prescription [64].
Regulatory and policy issues
Regulatory practices were rarely reported overall. Fre-
quency of regulatory visits varied across countries, with
only a third of PMVs in Nigeria reporting visits over the
last 2 years in contrast to drug stores in Tanzania, ma-
jority of whom had received visits over the last year
[28,54]. Low frequency of regulatory inspection was
blamed for poor regulatory compliance among pharma-
cies in Zaire (now the Democratic Republic of Congo),
where 87% of drugs were sold without prescription [8].
The sale of unregistered medicines was fairly common
in Kenya and Ghana. In Kenya for instance, only 5 out
of 12 brands of amodiaquine syrup were registered by
the regulatory authority [35], whereas 6-29% of pharma-
cies and 11-23% of LCSs were found selling various
brands of unregistered antimalarials in Ghana [73]. In
Tanzania, different patterns were observed across differ-
ent shop cadres; whereas 19 of 30 drug stores were
found stocking unregistered antimalarial imports, nearly
all pharmacies were reported to only stock registered
malaria medicines [54,74]. Other forms of regulatory in-
fringement included providing clinical management
without authorization in Uganda, and failure to display
practice permits in Tanzania [54,75]. Drug policy issues
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were poorly communicated in Tanzania overall, with
three-quarters of dispensers reporting that they heard
about malaria treatment policy changes over the radio
and other news media [7]. This may partly explain the
high availability of unrecommended treatments such as
artemisinin monotherapies in Tanzanian pharmacies and
drug stores [74,76].
Discussion
The role of SDSs in public health has expanded over re-
cent years, resulting in an overall increase in studies
looking at various dimensions of their characteristics
and performance, and ways of improving their impact. A
recent increase in studies on the topic was demonstrated
in the review, with nearly two thirds coming over the
last five years. The surge can be explained in part by the
fact that the Tanzanian authorities allowed upgrading of
part II drug stores into ADDOs, thus resulting in the
relatively high number of studies seen from Tanzania.
Majority of studies came from Anglophone countries,
possibly due to any one of two reasons; a weakness in
the search strategy, or an overall lack of interest in SDSs
by the biomedical communities in Francophone coun-
tries. Similar concerns have been expressed in previous
reviews in SSA [2,6]. Majority of studies were cross-
sectional descriptive surveys employing provider ques-
tionnaires and/or simulated clients for data collection.
Simulated client surveys have gained popularity over re-
cent years because of the ability to minimize bias
[77,78]. Studies included in the review were highly het-
erogeneous, reporting a wide range of outcomes includ-
ing characteristics of staff and shops, knowledge, and
reported and observed practices. This made it impossible
to pool estimates or assess overall patterns using any
quantitative methods. As a result, a structured narrative
synthesis was undertaken to describe the findings from
the studies. However, unlike the more rigorous meta-
analysis approach, the narrative synthesis approach gives
each study equal weight, regardless of sample size and
methodological rigour. Consequently, the risk of bias
can be expected to be higher in this type of review, thus
calling for a higher degree of caution when interpreting
findings. In an attempt to minimize this, we placed more
emphasis on discussing patterns that emerged across a
number of studies and/countries.
Overall, the presence of SDSs correlated positively
with population density, with majority operating either
in urban areas, or rural areas with larger populations.
Incidentally, these also happen to be areas with better
health facility networks [79,80]. As far as prices are
concerned, no consistent patterns were observed across
the countries. In some areas like Tanzania, ADDOs
operating in rural areas reportedly charged higher
prices for medicines in some areas, presumably to
cater for transport costs and compensate for low busi-
ness activity (although higher competition may also ex-
plain lower prices in urban locations). On the other
hand, non-pharmacy drug shops (usually found more
in rural locations) were reported to charge lower
prices compared to the more urban location-linked
pharmacies across a number of countries. This obser-
vation may reflect a number of factors, including
higher purchasing power among the urban clientele,
and higher operational costs in the usually larger
urban shops. More research needs to explore reasons
behind price variations, and find interventions that
may reduce such disparities. This is particularly im-
portant in the context of the roll-out of Global Fund
supported AMFm program, where prices are expected
to be standard across all subsidized artemisinin com-
bination therapies (ACTs) [81,82].
Two outcomes with important policy implications are
staff turnover and qualifications. Overall, low staff turn-
over can be expected to maximize benefits of introdu-
cing interventions such as training. Evidence points at
relatively low staff turnover, particularly among drug
shops and PMVs. It is not clear why this is the case, al-
though low capital base has been cited previously as one
possible reason [2]. Another possibility stems from the
fact that the lower cadre shops are more often manned
by owners compared to pharmacies. Of greater concern
perhaps, is the issue of unqualified staff serving clients,
even where SDSs carry registration certificates from
qualified persons. Although reported across all shop
cadres, this behaviour was particularly dire among
PMVs, some of whom went as far as employing school
going children to dispense medicines. Creation of lower
practice levels such as part II drug shops and allowing
non-pharmaceutical personnel to run SDSs are viewed
as policy responses to low numbers of pharmacists; thus
meant to ensure better access to medicines and health
information. However, the success of the strategy rides
on the expectation that license holders (usually people
with some health-related training) be available at the
premises at all times. The question is; what happens to
the quality of care when lower-level providers delegate
dispensing responsibilities further? Reliable information
on characteristics of staff manning SDSs is vital if policy-
makers are to make informed decisions on what roles
these providers should play. Regrettably though, this
knowledge remains inadequate, a view expressed in a
previous review on a related subject [2].
Staff knowledge was fairly good on areas such as drug
selection, but relatively poor on the more technical
aspects such as drug dosages and side-effects, particu-
larly among non-pharmacy drug shops. This is under-
standable, considering such shops are usually licensed to
only sell pre-packaged medicines. However, the role of
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non-pharmacy SDSs has been gradually expanding over
recent years, with Tanzania for instance, relicensing part
II drug stores into ADDOs, and granting the accredited
shops permission to sell a wider range of medicines.
This trend is likely to spread to other areas, particularly
following the roll out of the AMFm programme. If the
role of SDSs is to be bumped up without compromising
quality, comprehensive training approaches are vital.
This will ensure misconceptions about medicines are
addressed (see for instance, Rutebemberwa et al on how
auditory pain, a side-effects of quinine, was perceived to
be an indicator of how strong the drug was in Uganda,
and Dodoo et al on how fear of side-effects of amodia-
quine made clients prefer artemisinin monotherapy over
amodiaquine-containing ACTs in Ghana) [83,84]. The
observation that practice did not always reflect know-
ledge suggests that factors beyond staff awareness are
equally important in influencing practices. Unfortu-
nately, interventions for improving the quality of ser-
vices provided by SDS almost always entail training and
related strategies only [5,6]. More studies need to de-
scribe other factors, and how interventions can be
designed to achieve the highest quality. Goel et al, for
instance, identified client demand/expectations, phys-
ician practice and local regulatory factors as potential
determinants of pharmacy staff behaviour [85]. In this
review, demand was found to strongly influence drug se-
lection and dispensing. This can be inferred as resulting
from market forces, and presents a unique opportunity
for policy drivers to influence SDS behaviour through
manipulating the demand side preferences. This can be
achieved using mass media campaigns targeting perverse
community behaviours such as taking incomplete doses
of antibiotics. The idea of manipulating preferences to
influence private sector behaviour has been reported to
be effective in some settings [1].
Shop location was associated with several practices,
with clients visiting pharmacies in larger towns or afflu-
ent areas receiving better care compared to those in
smaller towns or poorer areas. This may have resulted
because individuals living in poorer areas had less know-
ledge on drugs (thus more likely to buy wrong medi-
cines), or it could be an indication of skewed
distribution of trained staff in favour of urban and afflu-
ent areas. However, such disparities may also occur if
staff in urban and affluent areas get more continuous
medical training opportunities overall. The observation
that rural shops offered credit more readily may reflect
better familiarity with the clients, or lower purchasing
power overall. This nonetheless points at differences in
the nature of relationships between SDSs and clients
across the two locations, thus underscoring the value of
recognizing rural-urban differences when designing
interventions to improve practice.
The high willingness to refer clients reported in some
studies is encouraging, although actual referral practices
were rarely ascertained in practice. Willingness to refer
clients where required presents an opportunity for col-
laborative partnerships between SDS and health facil-
ities. A similar arrangement formed the basis of a
considerably successful programme aimed at improving
community management of TB in Bolivia [86]. Such
partnerships may also expand the role of SDSs towards
preventive services, thus addressing concerns that retai-
lers over provide curative commodities at the expense of
advising and counselling clients on broader aspects of
health [29].
Few studies looked at regulatory factors overall. Where
this was done, the frequency of regulatory visits and se-
verity of sanctions were linked to regulatory compliance,
with lower frequency and less severe sanctions being
blamed for poor compliance. However, little has been
done to examine the exact relationship between regula-
tory enforcement and SDS performance overall, an ob-
servation also made nearly a decade and a half ago [85].
Concerns over evidence gaps on effectiveness of regula-
tion have been expressed in a previous review on SDSs
[6]. Finally, proper knowledge is required on the retail
sector, particularly considering their growing role in
public health. Furthermore, public health interventions
appear to be increasingly looking beyond the tradition-
ally legitimated categorization of providers, recognizing
instead the blurred boundaries between informal and
formal providers, and the fluid nature of line separating
legitimate and illegitimate practitioners [87]. As lower
levels of practice become increasingly embraced, infor-
mation on performance and determinants of SDS prac-
tices is required to inform policy on allocating
appropriate roles and designing interventions to improve
their practice.
Conclusion
Characteristics and practices of SDSs vary across coun-
tries and shop cadres. Overall, it appears that the prac-
tice of unqualified staff manning shops is common, even
where shops carry legitimate licenses. Although the de-
sign of pharmacies allowed for better communication
with clients, this was rarely done overall. Non-pharmacy
drug shop premises were generally more basic in struc-
ture. Differences in the structure and location of SDSs
should be considered when designing policy interven-
tions aimed at expanding their roles. Similarly, regula-
tions should be responsive to differences in the size,
location and nature of business of pharmacies and non-
pharmacy drug shops. Whereas majority of staff per-
formed had basic knowledge on drug choice, knowledge
on more technical, but equally useful aspects such as
side-effects was generally poor, particularly among non-
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pharmacy shops. As this is likely to be a result of non-
qualified staff manning SDSs, more innovative ways of
implementing regulatory enforcement need to be devel-
oped. With regard to dispensing practices, evidence
points at client demand as an important influence,
meaning it would be difficult to influence dispensing
practices without involving certain aspects of public
awareness. Strategies for manipulating demand-side pre-
ferences such as social marketing and targeted subsidies
could generate additional benefit if included as part of
interventions for improving dispensing practices of SDS.
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